320 related articles for article (PubMed ID: 27126953)
1. Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs.
Park MJ; Lee SY; Moon SJ; Son HJ; Lee SH; Kim EK; Byun JK; Shin DY; Park SH; Yang CW; Cho ML
Transl Res; 2016 Jul; 173():115-130. PubMed ID: 27126953
[TBL] [Abstract][Full Text] [Related]
2. Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance.
Lee SY; Lee SH; Yang EJ; Kim EK; Kim JK; Shin DY; Cho ML
PLoS One; 2015; 10(9):e0135858. PubMed ID: 26360050
[TBL] [Abstract][Full Text] [Related]
3. GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation.
Park MJ; Lee SH; Lee SH; Kim EK; Lee EJ; Moon YM; La Cho M
J Transl Med; 2016 Jul; 14(1):206. PubMed ID: 27391226
[TBL] [Abstract][Full Text] [Related]
4. Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance.
Lee SK; Park MJ; Jhun JY; Beak JA; Choi JW; Rye JY; Jang JW; Bae SH; Yoon SK; Choi HJ; You YK; Cho ML; Choi JY
Front Immunol; 2020; 11():581728. PubMed ID: 33488583
[TBL] [Abstract][Full Text] [Related]
5. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
Yao Y; Wang L; Zhou J; Zhang X
J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
[TBL] [Abstract][Full Text] [Related]
6. PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.
Lee SH; Moon SJ; Park MJ; Kim EK; Moon YM; Cho ML
Immunol Lett; 2014 Jul; 160(1):79-88. PubMed ID: 24718277
[TBL] [Abstract][Full Text] [Related]
7. Blocking activator protein 1 activity in donor cells reduces severity of acute graft-versus-host disease through reciprocal regulation of IL-17-producing T cells/regulatory T cells.
Park MJ; Moon SJ; Lee SH; Kim EK; Yang EJ; Min JK; Park SH; Kim HY; Yang CW; Cho ML
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1112-20. PubMed ID: 24813170
[TBL] [Abstract][Full Text] [Related]
8. Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice.
Yao J; Wei C; Wang JY; Zhang R; Li YX; Wang LS
World J Gastroenterol; 2015 Jun; 21(21):6572-81. PubMed ID: 26074695
[TBL] [Abstract][Full Text] [Related]
9. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
10. Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells.
Park MJ; Moon SJ; Lee SH; Yang EJ; Min JK; Cho SG; Yang CW; Park SH; Kim HY; Cho ML
PLoS One; 2013; 8(6):e67171. PubMed ID: 23840617
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy.
Shi WY; Xiao D; Wang L; Dong LH; Yan ZX; Shen ZX; Chen SJ; Chen Y; Zhao WL
Cell Death Dis; 2012 Mar; 3(3):e275. PubMed ID: 22378068
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin E ameliorates acute graft-versus-host disease by modulating Th17 cell subsets and inhibiting STAT3 activation.
Kim SY; Park MJ; Kwon JE; Jung KA; Jhun JY; Lee SY; Seo HB; Ryu JY; Beak JA; Choi JY; Cho ML
Immunol Lett; 2018 Nov; 203():62-69. PubMed ID: 30240636
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
14. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
15. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells.
Zeiser R; Leveson-Gower DB; Zambricki EA; Kambham N; Beilhack A; Loh J; Hou JZ; Negrin RS
Blood; 2008 Jan; 111(1):453-62. PubMed ID: 17967941
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 21 blockade modulates activated T- and B-cell homeostasis via B-cell activating factor pathway-mediated inhibition in a murine model of acute graft-versus-host disease.
Lim JY; Park MJ; Im KI; Kim N; Park HS; Lee SH; Kim EK; Nam YS; Lee ES; Cho ML; Cho SG
Exp Hematol; 2015 Jan; 43(1):23-31.e1-2. PubMed ID: 25246268
[TBL] [Abstract][Full Text] [Related]
18. Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.
Jia H; Zhao T; Ji Y; Jia X; Ren W; Li C; Li M; Xiao Y; Wang H; Xu K
Cell Death Dis; 2016 Dec; 7(12):e2507. PubMed ID: 27906171
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease.
Sugiyama H; Maeda Y; Nishimori H; Yamasuji Y; Matsuoka K; Fujii N; Kondo E; Shinagawa K; Tanaka T; Takeuchi K; Teshima T; Tanimoto M
Biol Blood Marrow Transplant; 2014 Feb; 20(2):183-91. PubMed ID: 24333142
[TBL] [Abstract][Full Text] [Related]
20. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
